Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion
February 12th, 2018
54.8K views
The goal of this protocol is to obtain high viability and high yield of hepatocytes and sinusoidal endothelial cells from liver. This is accomplished by perfusing the liver with a type IV collagenase solution via the portal vein, followed by differential centrifugation to obtain hepatocytes and sinusoidal endothelial cells.
Overview
This protocol outlines a method for performing Mouse Liver Perfusion to isolate high yields of hepatocytes and sinusoidal endothelial cells. The technique involves perfusing the liver with a collagenase solution and utilizing differential centrifugation to purify specific liver cell populations.
Key Study Components
Area of Science
- Hepatology
- Cell Biology
- In Vitro Assays
Background
- Understanding liver cell functions is crucial for hepatology research.
- Isolation of specific liver cells aids in studying their roles in various assays.
- High viability and yield of cells are essential for experimental success.
- Visual assessment of liver digestion is important for maintaining cell integrity.
Purpose of Study
- To develop a reliable method for isolating hepatocytes and sinusoidal endothelial cells.
- To enhance the understanding of liver cell functions in research.
- To provide a detailed protocol for researchers in the field.
Methods Used
- Perfusion of the liver with a collagenase solution via the portal vein.
- Differential centrifugation to separate cell populations.
- Density gradient centrifugation for further purification of sinusoidal endothelial cells.
- Visual inspection and careful handling to ensure cell viability.
Main Results
- Successful isolation of hepatocytes and sinusoidal endothelial cells.
- High cell viability and yield achieved through the described method.
- Clear visualization of liver micro-anatomy through scanning electron microscopy.
- Protocol provides a framework for future hepatology studies.
Conclusions
- The protocol is effective for isolating liver cell populations.
- High yield and viability of cells support their use in research.
- Method can facilitate advancements in understanding liver biology.
Frequently Asked Questions
What is the main goal of the liver perfusion protocol?
The main goal is to isolate high viability and yield of hepatocytes and sinusoidal endothelial cells from the liver.
Why is visual demonstration important in this protocol?
Visual demonstration helps ensure the liver is optimally digested, preserving cell viability.
What are the key steps in the perfusion process?
Key steps include catheter placement, perfusion with PBS, and collagenase solution, followed by centrifugation.
How are sinusoidal endothelial cells isolated?
They are isolated using density gradient centrifugation after initial cell separation.
What advantages does this method offer?
The method provides high yields of specific liver cell populations, which are crucial for various assays.
Can this protocol be adapted for other types of cells?
While primarily designed for liver cells, adaptations may be possible for other tissues with similar structures.
Executive Industry Relevance
This protocol enables reliable isolation of primary hepatocytes and sinusoidal endothelial cells from mouse liver, providing a physiologically relevant system for studying liver-specific drug metabolism and toxicity. The method supports early discovery by delivering high-yield, viable cells for in vitro assays that inform target validation and lead optimization. By minimizing ischemia-reperfusion injury through portal vein catheterization, it enhances data reproducibility across discovery and preclinical workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Provides a disease-relevant system for interrogating hepatic target engagement and pathway modulation in vitro.
- Operational Value: Delivers consistent hepatocyte yields for functional assays that de-risk mechanistic hypotheses.
Screening & Assay Development
- Scientific Value: Enables preparation of purified sinusoidal endothelial cells for co-culture models that improve assay predictability.
- Operational Value: Supports standardized cell isolation for scalable screening platforms assessing compound effects on liver sinusoidal signaling.
Translational & Preclinical Research
- Scientific Value: Offers a translational biomarker-aligned system for studying liver-specific drug responses prior to in vivo testing.
- Operational Value: Facilitates continuity from discovery to preclinical evaluation by supplying well-characterized primary liver cells.
Pipeline & Workflow Integration
The method fits within the discovery continuum, supporting early biology through lead identification by supplying validated primary hepatocytes for ADME/Tox screening and mechanistic studies.
- Discovery Biology: Enables hypothesis testing of liver targets using primary cells that retain in vivo-like functionality.
- Screening: Delivers reproducible hepatocyte and SEC preparations for quantitative compound screening in metabolic and inflammatory pathways.
- Analytics: Generates viable cell lysates and cultured cells for biochemical readouts such as enzyme activity, cytokine release, and barrier integrity.
- Translational Research: Supports preclinical continuity by providing cells that reflect murine liver biology for target validation studies.
- Enterprise Reuse: Establishes a reusable isolation workflow for generating consistent liver cell preparations across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in liver-related target validation through use of primary, physiologically relevant cells.
- Operational Value: Ensures standardization and reproducibility via a well-defined perfusion and centrifugation protocol.
- Strategic Value: Reduces late-stage attrition by improving early detection of liver-mediated liabilities.
- Portfolio Impact: Enables risk-informed prioritization of compounds based on hepatic cell-based assay outcomes.
Implementation Considerations
- Requires expertise in mouse surgery and vascular catheterization for successful portal vein access.
- Depends on perfusion pumps, centrifuges, and sterile tissue culture facilities for cell processing.
- Necessitates standardization of collagenase digestion times and buffer conditions across operators.
- Involves adaptation considerations when applying the protocol to different mouse strains or ages.
- Limited by the technical challenge of portal vein catheterization in smaller mice (18–25 g), which may affect throughput.
Biopharma FAQs
Why does portal vein catheterization improve hepatocyte yield in liver perfusion?
Using the portal vein for catheterization limits contamination from other cell types and reduces ischemia-reperfusion injury, which helps preserve hepatocyte viability and yield during perfusion.
How does collagenase perfusion enable isolation of hepatocytes and sinusoidal endothelial cells?
Collagenase digestion breaks down liver extracellular matrix, allowing release of hepatocytes and non-parenchymal cells, which are then separated by differential centrifugation and filtration steps.
What role does density gradient centrifugation play in sinusoidal endothelial cell purification?
Density gradient centrifugation using Percoll solutions isolates sinusoidal endothelial cells based on buoyant density, enabling separation from Kupffer cells and other non-parenchymal populations.
Why are replication and consistency important in hepatocyte isolation for cross-functional collaboration?
Consistent cell yield and viability across preparations ensure reliable assay results, enabling teams to compare data confidently across discovery and preclinical projects.
What analytical outputs are generated from isolated hepatocytes and sinusoidal endothelial cells?
The isolated cells can be used for culturing, lysate preparation, or downstream biochemical assessments such as enzyme activity, metabolism, and signaling assays to support drug discovery decisions.
